Home/Filings/4/0000921895-21-000617
4//SEC Filing

Rossi Michael A. 4

Accession 0000921895-21-000617

CIK 0001123494other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:26 PM ET

Size

7.9 KB

Accession

0000921895-21-000617

Insider Transaction Report

Form 4
Period: 2021-03-01
Rossi Michael A.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2021-03-01+38,462185,738 total
  • Award

    Common Stock

    2021-03-01+36,876222,614 total
Footnotes (4)
  • [F1]Represents an award of 38,462 restricted stock units that will vest in three equal installments on December 31, 2021, 2022 and 2023, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person.
  • [F2]Includes (a) the award described in footnote (1) above, (b) 47,753 remaining restricted stock units that will vest on July 18, 2021 and 2022, (c) 32,319 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023, (d) 43,092 restricted stock units with performance based vesting conditions tied to relative total shareholder return that will vest on June 11, 2021, 2022 and 2023, and (e) 24,112 shares of common stock beneficially owned by the Reporting Person.
  • [F3]Represents an award of 36,876 restricted stock units with performance based vesting conditions. These restricted stock units will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from March 1, 2021 to the earlier of (i) December 31, 2023, and (ii) the date of a change of control (the "Measurement Period"), measured relative to the Russell 2000 index and based on the 20-day trading average beginning on the first day of the Measurement Period and ending on the last day of the Measurement Period, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported.
  • [F4]Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above.

Issuer

HARVARD BIOSCIENCE INC

CIK 0001123494

Entity typeother

Related Parties

1
  • filerCIK 0001783869

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:26 PM ET
Size
7.9 KB